Awakn Life Sciences Q1 Revenue Increased 24%
June 19, 2022 at 01:02 AM EDT
Awakn Life Sciences is a biotechnology company, researching, developing, and commercializing therapeutics to treat addiction with a near-term focus on Alcohol Use Disorder and its revenue increased 24% from the previous quarter.
